The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ongoing, first-in-human, phase I dose escalation study of the investigational CD47-blocker TTI-622 in patients with advanced relapsed or refractory lymphoma.
 
Krish Patel
Honoraria - Dava Oncology
Consulting or Advisory Role - AstraZeneca; BeiGene; Celgene; Genentech; Juno Therapeutics; Pharmacyclics
Speakers' Bureau - AstraZeneca; Celgene; Genentech; Pharmacyclics/Janssen
Research Funding - Aptevo Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Curis (Inst); Kite/Gilead (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Sunesis Pharmaceuticals (Inst); Takeda (Inst); Trillium Therapeutics (Inst); Xencor (Inst)
 
Michael B. Maris
No Relationships to Disclose
 
Bruce D. Cheson
Consulting or Advisory Role - Abbvie; Astellas Pharma; AstraZeneca; Bayer; Celgene; Epizyme; Gilead Sciences; Karyopharm Therapeutics; Morphosys; Parexel; Pharmacyclics/Janssen; Roche/Genentech; SymBio Pharmaceuticals; TG Therapeutics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Roche/Genentech (Inst); Seagen (Inst); TG Therapeutics (Inst); Trillium Therapeutics (Inst)
Travel, Accommodations, Expenses - SymBio Pharmaceuticals
 
Jeffrey A. Zonder
Consulting or Advisory Role - Alnylam; Amgen; Bristol-Myers Squibb; Caelum Biosciences; Celgene; Intellia Therapeutics; Janssen; Oncotherapeutics; Prothena; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst)
 
Alexander M. Lesokhin
Honoraria - Amgen; Bristol-Myers Squibb; Genmab
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen Oncology (Inst); Sanofi (Inst); Trillium Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
Gottfried Von Keudell
No Relationships to Disclose
 
Erlene Kuizon Seymour
Research Funding - Karyopharm Therapeutics
 
Gloria H.Y. Lin
Employment - Trillium Therapeutics
Stock and Other Ownership Interests - Trillium Therapeutics
Consulting or Advisory Role - BTInsight Consulting (I)
Patents, Royalties, Other Intellectual Property - Trillium Therapeutics
 
Tina Catalano
Employment - Trillium Therapeutics
Stock and Other Ownership Interests - Trillium Therapeutics
 
Yaping Shou
Employment - Takeda; Trillium Therapeutics
Leadership - Trillium Therapeutics
Stock and Other Ownership Interests - Trillium Therapeutics
 
Swaminathan Padmanabhan Iyer
Research Funding - Arog (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Incyte (Inst); Novartis (Inst); Takeda (Inst)
 
Radhakrishnan Ramchandren
Consulting or Advisory Role - Bristol-Myers Squibb; Pharmacyclics/Janssen; Sandoz-Novartis; Seagen
Research Funding - Genentech (Inst); Janssen (Inst); Merck (Inst); Seagen (Inst)